Get started
Author

Oswald Van Cutsem

Prognostic factors for survival in advanced non-small-cell lung cancer: univariate and multivariate analyses including recursive partitioning and amalgamation algorithms in 1,052 patients. The European Lung Cancer Working Party.
1995 · M Paesmans, J P Sculier, et al. · Journal of Clinical Oncology · 386
Prognostic factors for patients with small cell lung carcinoma
2000 · M. Paesmans., J. P. Sculier, et al. · Cancer · 225
Response to chemotherapy has predictive value for further survival of patients with advanced non-small cell lung cancer: 10 years experience of the european lung cancer working party
1997 · M Paesmans, J.P Sculier, et al. · European Journal of Cancer · 83
Multiple-drug weekly chemotherapy versus standard combination regimen in small-cell lung cancer: a phase III randomized study conducted by the European Lung Cancer Working Party.
1993 · J P Sculier, M Paesmans, et al. · Journal of Clinical Oncology · 78
Randomized trial comparing induction chemotherapy versus induction chemotherapy followed by maintenance chemotherapy in small-cell lung cancer. European Lung Cancer Working Party.
1996 · J P Sculier, M Paesmans, et al. · Journal of Clinical Oncology · 71
A three-arm phase III randomised trial assessing, in patients with extensive-disease small-cell lung cancer, accelerated chemotherapy with support of haematological growth factor or oral antibiotics
2001 · for the European Lung Cancer Working Party, J P Sculier, et al. · British Journal of Cancer · 67
A randomised phase III trial comparing consolidation treatment with further chemotherapy to chest irradiation in patients with initially unresectable locoregional non-small-cell lung cancer responding to induction chemotherapy
1999 · J.P. Sculier, M. Paesmans, et al. · Annals of Oncology · 36
PDF
Long-term survival after chemotherapy containing platinum derivatives in patients with advanced unresectable non-small cell lung cancer
1994 · J.P. Sculier, M. Paesmans, et al. · European Journal of Cancer · 34
Prognostic factors for response to chemotherapy containing platinum derivatives in patients with unresectable non-small cell lung cancer (NSCLC)
1996 · M. Borges, J.P. Sculier, et al. · Lung Cancer · 30
Chemotherapy improves low performance status lung cancer patients
2007 · J. P. Sculier, J. J. Lafitte, et al. · European Respiratory Journal · 27
PDF
A phase II study testing paclitaxel as second-line single agent treatment for patients with advanced non-small cell lung cancer failing after a first-line chemotherapy
2002 · J.P. Sculier, T. Berghmans, et al. · Lung Cancer · 27
A phase III randomised trial comparing sequential chemotherapy using cisplatin-based regimen and paclitaxel to cisplatin-based chemotherapy alone in advanced non-small-cell lung cancer
2007 · J.P. Sculier, J.J. Lafitte, et al. · Annals of Oncology · 20
PDF
A phase II randomised trial comparing the cisplatin–etoposide combination chemotherapy with or without carboplatin as second-line therapy for small-cell lung cancer
2002 · J.P. Sculier, J.J. Lafitte, et al. · Annals of Oncology · 19
Evaluation of the TN sub-staging in patients with initially unresectable stage III non-small cell lung cancer treated by induction chemotherapy
1998 · J.P. Sculier, M. Paesmans, et al. · Lung Cancer · 14
Second-line paclitaxel in non-small cell lung cancer initially treated with cisplatin: a study by the European Lung Cancer Working Party
2007 · for the European Lung Cancer Working Party, T Berghmans, et al. · British Journal of Cancer · 11
PDF
[Prognostic factors in advanced stage non-small cell bronchial cancer: experiences of the European Lung Cancer Working Party].
1997 · J P Sculier, M Paesmans, et al. · PubMed · 9
[Diagnosis of intralobar pulmonary sequestration using helical computed tomography angiography: apropos of 3 patients].
1999 · B Coulier, P Mailleux, et al. · PubMed · 8
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5-fluorouracil
1994 · J. Klastersky, J.P. Sculier, et al. · Annals of Oncology · 8
Validation and comparison of several published prognostic systems for patients with small cell lung cancer
2011 · M. Paesmans, J.J. Lafitte, et al. · European Respiratory Journal · 7
PDF
European Lung Cancer Working Party Clinical Practice Guidelines. Non-Small Cell Lung Cancer: III. Metastatic disease
2006 · Costas G. Alexopoulos, Alard, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 7
A four-drug combination chemotherapy with cisplatin, mitomycin, vindesine and 5 fluorouracile: a regimen associated with major toxicity in patients with advanced non-small cell lung cancer
1994 · J. Klastersky, J.P. Sculier, et al. · Lung Cancer · 7
Bronchial lipoma : an unusual cause of pleural empyema
2015 · S. Lanotte, R. Frognier, et al. · Journal of the Belgian Society of Radiology · 6
PDF
A phase III randomised trial comparing sequential to standard chemotherapy in advanced non-small cell lung cancer (NSCLC)
2006 · J. Sculier, J. Lafitte, et al. · Journal of Clinical Oncology · 6
Prognostic factors analysis for response to chemotherapy and survival in a prospective cohort of patients with unresectable locoregional non small cell lung cancer initially treated by induction chemotherapy
1999 · Jean‐Paul Sculier, Marianne Paesmans, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 4
A three-arm phase III randomised trial testing accelerated chemotherapy with GM-CSF or cotrimoxazole in extensive disease smal-cell lung cancer
2001 · Jean‐Paul Sculier, Jean-Paul Lecomte, et al. · Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) · 3
Works count: 53
Citation count: 1,208
H-index: 14
I10-index: 15
Year
Topic
Type